HDAC Modulator

Cat.No. Product Name Information Product Use Citations Product Validations
S7617 Tasquinimod Tasquinimod (ABR-215050) is an orally active antiangiogenic agent by allosterically inhibiting HDAC4 signalling. Phase 3.
Signal Transduct Target Ther, 2023, 8(1):11
Nat Commun, 2022, 13(1):1481
Int J Biol Sci, 2022, 18(15):5724-5739
Verified customer review of Tasquinimod